CORBEVAX, a new patent-free COVID-19 vaccine, could be a pandemic game changer globally - The Conversation

( January 19, 2019; The Conversation )

Description: "CORBEVAX is anticipated to significantly expand vaccine access to people in low- and middle-income countries."

All COVID-19 vaccines teach the immune system how to recognize the virus and prepare the body to mount an attack. The CORBEVAX vaccine is a protein subunit vaccine. It uses a harmless piece of the spike protein from the coronavirus that causes COVID-19 to stimulate and prepare the immune system for future encounters with the virus.

Unlike the three vaccines approved in the U.S. – Pfizer and Moderna’s mRNA vaccines and Johnson & Johnson’s viral vector vaccine, which provide the body instructions on how to produce the spike protein – CORBEVAX delivers the spike protein to the body directly. Like those other approved COVID-19 mRNA vaccines, CORBEVAX also requires two doses.

Testing Steem/blockchain posting after implementation of Document listeners for field validation (TODO) as well as rudimentary tag/keyword scraping.

Read the rest from The Conversation: CORBEVAX, a new patent-free COVID-19 vaccine, could be a pandemic game changer globally